norcantharidin has been researched along with Osteogenic Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Z; Liu, C; Lu, R; Lu, Y; Song, K; Sun, H; Wang, Q; Zhao, F; Zheng, C | 1 |
| Chen, F; Cui, K; Li, X; Mei, L; Sang, W; Zhang, Y | 1 |
2 other study(ies) available for norcantharidin and Osteogenic Sarcoma
| Article | Year |
|---|---|
Strontium/Chitosan/Hydroxyapatite/Norcantharidin Composite That Inhibits Osteosarcoma and Promotes Osteogenesis In Vitro.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biocompatible Materials; Bone Development; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Chitosan; Freeze Drying; Humans; Hydroxyapatites; Microscopy, Electron, Scanning; Nanoparticles; Necrosis; Osteoblasts; Osteogenesis; Osteosarcoma; Particle Size; Sincalide; Spectroscopy, Fourier Transform Infrared; Strontium; X-Ray Diffraction | 2020 |
Norcantharidin inhibits proliferation and promotes apoptosis via c-Met/Akt/mTOR pathway in human osteosarcoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Bone Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Osteosarcoma; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; S Phase; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2019 |